aluates Reports

$ 0.0

Automative

Human Alpha1-Proteinase Inhibitor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-10O12234

Global Human Alpha1 Proteinase Inhibitor Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Human Alpha1-Proteinase Inhibitor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10O12234

Report

September 2024

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

Kamada

CSL Behring

Grifols S A

Human Alpha1-Proteinase Inhibitor - Market Size

The global market for Human Alpha1-Proteinase Inhibitor was estimated to be worth US$ 218 million in 2023 and is forecast to a readjusted size of US$ 293.1 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030

Human Alpha1-Proteinase Inhibitor - Market

Alpha1-Proteinase Inhibitor (Human), is a sterile, stable, lyophilized preparation of highly purified human alpha1-proteinase inhibitor (A1-PI)

The market growth can be attributed to several factors. Firstly, increasing awareness and improved diagnosis of AATD have led to a better identification of patients with this condition, driving the demand for Alpha1-PI therapy. Additionally, advancements in biotechnology and protein manufacturing techniques have contributed to the development of highly purified and more effective Alpha1-PI products, offering improved treatment options for patients.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Alpha1-Proteinase Inhibitor, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Alpha1-Proteinase Inhibitor by region & country, by Type, and by Application.

The Human Alpha1-Proteinase Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Alpha1-Proteinase Inhibitor.

Market Segmentation

Scope of Human Alpha1-Proteinase Inhibitor - Market Report

Report Metric	Details
Report Name	Human Alpha1-Proteinase Inhibitor - Market
Forecasted market size in 2030	US$ 293.1 million
CAGR	4.2%
Forecasted years	2024 - 2030
Segment by Type:	0.5g 1g
Segment by Application	Hospital Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Kamada, Grifols, CSL Behring
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Alpha1-Proteinase Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Alpha1-Proteinase Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Alpha1-Proteinase Inhibitor in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Human Alpha1-Proteinase Inhibitor - Market size in 2030?

Ans: The Human Alpha1-Proteinase Inhibitor - Market size in 2030 will be US$ 293.1 million.

Who are the main players in the Human Alpha1-Proteinase Inhibitor - Market report?

Ans: The main players in the Human Alpha1-Proteinase Inhibitor - Market are Takeda, Kamada, Grifols, CSL Behring

What are the Application segmentation covered in the Human Alpha1-Proteinase Inhibitor - Market report?

Ans: The Applications covered in the Human Alpha1-Proteinase Inhibitor - Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Human Alpha1-Proteinase Inhibitor - Market report?

Ans: The Types covered in the Human Alpha1-Proteinase Inhibitor - Market report are 0.5g, 1g

Recommended Reports

Human Protein Markets

Inhibitor & API Drugs

Proteinase & Enzyme Markets

1 Market Overview

1.1 Human Alpha1-Proteinase Inhibitor Product Introduction

1.2 Global Human Alpha1-Proteinase Inhibitor Market Size Forecast

1.2.1 Global Human Alpha1-Proteinase Inhibitor Sales Value (2019-2030)

1.2.2 Global Human Alpha1-Proteinase Inhibitor Sales Volume (2019-2030)

1.2.3 Global Human Alpha1-Proteinase Inhibitor Sales Price (2019-2030)

1.3 Human Alpha1-Proteinase Inhibitor Market Trends & Drivers

1.3.1 Human Alpha1-Proteinase Inhibitor Industry Trends

1.3.2 Human Alpha1-Proteinase Inhibitor Market Drivers & Opportunity

1.3.3 Human Alpha1-Proteinase Inhibitor Market Challenges

1.3.4 Human Alpha1-Proteinase Inhibitor Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Human Alpha1-Proteinase Inhibitor Players Revenue Ranking (2023)

2.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Company (2019-2024)

2.3 Global Human Alpha1-Proteinase Inhibitor Players Sales Volume Ranking (2023)

2.4 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Company Players (2019-2024)

2.5 Global Human Alpha1-Proteinase Inhibitor Average Price by Company (2019-2024)

2.6 Key Manufacturers Human Alpha1-Proteinase Inhibitor Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Human Alpha1-Proteinase Inhibitor Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Human Alpha1-Proteinase Inhibitor

2.9 Human Alpha1-Proteinase Inhibitor Market Competitive Analysis

2.9.1 Human Alpha1-Proteinase Inhibitor Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Human Alpha1-Proteinase Inhibitor Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Alpha1-Proteinase Inhibitor as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 0.5g

3.1.2 1g

3.2 Global Human Alpha1-Proteinase Inhibitor Sales Value by Type

3.2.1 Global Human Alpha1-Proteinase Inhibitor Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Human Alpha1-Proteinase Inhibitor Sales Value, by Type (2019-2030)

3.2.3 Global Human Alpha1-Proteinase Inhibitor Sales Value, by Type (%) (2019-2030)

3.3 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Type

3.3.1 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Human Alpha1-Proteinase Inhibitor Sales Volume, by Type (2019-2030)

3.3.3 Global Human Alpha1-Proteinase Inhibitor Sales Volume, by Type (%) (2019-2030)

3.4 Global Human Alpha1-Proteinase Inhibitor Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.2 Global Human Alpha1-Proteinase Inhibitor Sales Value by Application

4.2.1 Global Human Alpha1-Proteinase Inhibitor Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Human Alpha1-Proteinase Inhibitor Sales Value, by Application (2019-2030)

4.2.3 Global Human Alpha1-Proteinase Inhibitor Sales Value, by Application (%) (2019-2030)

4.3 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Application

4.3.1 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Human Alpha1-Proteinase Inhibitor Sales Volume, by Application (2019-2030)

4.3.3 Global Human Alpha1-Proteinase Inhibitor Sales Volume, by Application (%) (2019-2030)

4.4 Global Human Alpha1-Proteinase Inhibitor Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Human Alpha1-Proteinase Inhibitor Sales Value by Region

5.1.1 Global Human Alpha1-Proteinase Inhibitor Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Human Alpha1-Proteinase Inhibitor Sales Value by Region (2019-2024)

5.1.3 Global Human Alpha1-Proteinase Inhibitor Sales Value by Region (2025-2030)

5.1.4 Global Human Alpha1-Proteinase Inhibitor Sales Value by Region (%), (2019-2030)

5.2 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region

5.2.1 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (2019-2024)

5.2.3 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (2025-2030)

5.2.4 Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (%), (2019-2030)

5.3 Global Human Alpha1-Proteinase Inhibitor Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

5.4.2 North America Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

5.5.2 Europe Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

5.6.2 Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

5.7.2 South America Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

5.8.2 Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Value

6.2.1 Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.2.2 Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.3.2 United States Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Human Alpha1-Proteinase Inhibitor Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.4.2 Europe Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Human Alpha1-Proteinase Inhibitor Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.5.2 China Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.5.3 China Human Alpha1-Proteinase Inhibitor Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.6.2 Japan Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Human Alpha1-Proteinase Inhibitor Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.7.2 South Korea Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Human Alpha1-Proteinase Inhibitor Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.8.2 Southeast Asia Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Human Alpha1-Proteinase Inhibitor Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Human Alpha1-Proteinase Inhibitor Sales Value, 2019-2030

6.9.2 India Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.9.3 India Human Alpha1-Proteinase Inhibitor Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Company Information

7.1.2 Takeda Introduction and Business Overview

7.1.3 Takeda Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Takeda Human Alpha1-Proteinase Inhibitor Product Offerings

7.1.5 Takeda Recent Development

7.2 Kamada

7.2.1 Kamada Company Information

7.2.2 Kamada Introduction and Business Overview

7.2.3 Kamada Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Kamada Human Alpha1-Proteinase Inhibitor Product Offerings

7.2.5 Kamada Recent Development

7.3 Grifols

7.3.1 Grifols Company Information

7.3.2 Grifols Introduction and Business Overview

7.3.3 Grifols Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Grifols Human Alpha1-Proteinase Inhibitor Product Offerings

7.3.5 Grifols Recent Development

7.4 CSL Behring

7.4.1 CSL Behring Company Information

7.4.2 CSL Behring Introduction and Business Overview

7.4.3 CSL Behring Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

7.4.4 CSL Behring Human Alpha1-Proteinase Inhibitor Product Offerings

7.4.5 CSL Behring Recent Development

8 Industry Chain Analysis

8.1 Human Alpha1-Proteinase Inhibitor Industrial Chain

8.2 Human Alpha1-Proteinase Inhibitor Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Human Alpha1-Proteinase Inhibitor Sales Model

8.5.2 Sales Channel

8.5.3 Human Alpha1-Proteinase Inhibitor Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Takeda

Kamada

CSL Behring

Grifols S A

List of Tables

Table 1. Human Alpha1-Proteinase Inhibitor Market Trends

Table 2. Human Alpha1-Proteinase Inhibitor Market Drivers & Opportunity

Table 3. Human Alpha1-Proteinase Inhibitor Market Challenges

Table 4. Human Alpha1-Proteinase Inhibitor Market Restraints

Table 5. Global Human Alpha1-Proteinase Inhibitor Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Company (2019-2024)

Table 7. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Human Alpha1-Proteinase Inhibitor Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Human Alpha1-Proteinase Inhibitor Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Human Alpha1-Proteinase Inhibitor Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Human Alpha1-Proteinase Inhibitor Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Human Alpha1-Proteinase Inhibitor

Table 13. Global Human Alpha1-Proteinase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Alpha1-Proteinase Inhibitor as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Alpha1-Proteinase Inhibitor Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Human Alpha1-Proteinase Inhibitor Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Human Alpha1-Proteinase Inhibitor Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Human Alpha1-Proteinase Inhibitor Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Human Alpha1-Proteinase Inhibitor Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Human Alpha1-Proteinase Inhibitor Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Human Alpha1-Proteinase Inhibitor Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Human Alpha1-Proteinase Inhibitor Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Human Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Human Alpha1-Proteinase Inhibitor Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Human Alpha1-Proteinase Inhibitor Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Human Alpha1-Proteinase Inhibitor Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Human Alpha1-Proteinase Inhibitor Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Human Alpha1-Proteinase Inhibitor Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Human Alpha1-Proteinase Inhibitor Sales Value by Region (2019-2024) & (%)

Table 44. Global Human Alpha1-Proteinase Inhibitor Sales Value by Region (2025-2030) & (%)

Table 45. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (2019-2024) & (%)

Table 49. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Region (2025-2030) & (%)

Table 50. Global Human Alpha1-Proteinase Inhibitor Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Human Alpha1-Proteinase Inhibitor Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Volume, (2025-2030) & (K Units)

Table 57. Takeda Company Information

Table 58. Takeda Introduction and Business Overview

Table 59. Takeda Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Takeda Human Alpha1-Proteinase Inhibitor Product Offerings

Table 61. Takeda Recent Development

Table 62. Kamada Company Information

Table 63. Kamada Introduction and Business Overview

Table 64. Kamada Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Kamada Human Alpha1-Proteinase Inhibitor Product Offerings

Table 66. Kamada Recent Development

Table 67. Grifols Company Information

Table 68. Grifols Introduction and Business Overview

Table 69. Grifols Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Grifols Human Alpha1-Proteinase Inhibitor Product Offerings

Table 71. Grifols Recent Development

Table 72. CSL Behring Company Information

Table 73. CSL Behring Introduction and Business Overview

Table 74. CSL Behring Human Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. CSL Behring Human Alpha1-Proteinase Inhibitor Product Offerings

Table 76. CSL Behring Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Human Alpha1-Proteinase Inhibitor Downstream Customers

Table 80. Human Alpha1-Proteinase Inhibitor Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Alpha1-Proteinase Inhibitor Product Picture

Figure 2. Global Human Alpha1-Proteinase Inhibitor Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Human Alpha1-Proteinase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Human Alpha1-Proteinase Inhibitor Sales Volume (2019-2030) & (K Units)

Figure 5. Global Human Alpha1-Proteinase Inhibitor Sales Price (2019-2030) & (USD/Unit)

Figure 6. Human Alpha1-Proteinase Inhibitor Report Years Considered

Figure 7. Global Human Alpha1-Proteinase Inhibitor Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Human Alpha1-Proteinase Inhibitor Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Alpha1-Proteinase Inhibitor Revenue in 2023

Figure 10. Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 0.5g Picture

Figure 12. 1g Picture

Figure 13. Global Human Alpha1-Proteinase Inhibitor Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Human Alpha1-Proteinase Inhibitor Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Human Alpha1-Proteinase Inhibitor Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Human Alpha1-Proteinase Inhibitor Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Pharmacy

Figure 20. Global Human Alpha1-Proteinase Inhibitor Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Human Alpha1-Proteinase Inhibitor Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Human Alpha1-Proteinase Inhibitor Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Human Alpha1-Proteinase Inhibitor Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Human Alpha1-Proteinase Inhibitor Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Human Alpha1-Proteinase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Human Alpha1-Proteinase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Human Alpha1-Proteinase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Human Alpha1-Proteinase Inhibitor Sales Volume (%), (2019-2030)

Figure 37. United States Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Human Alpha1-Proteinase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Human Alpha1-Proteinase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 43. China Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 45. China Human Alpha1-Proteinase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Human Alpha1-Proteinase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Human Alpha1-Proteinase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Human Alpha1-Proteinase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 55. India Human Alpha1-Proteinase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Human Alpha1-Proteinase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 57. India Human Alpha1-Proteinase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 58. Human Alpha1-Proteinase Inhibitor Industrial Chain

Figure 59. Human Alpha1-Proteinase Inhibitor Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alpha Protease Inhibitor Market Research Report 2025

Trypsin Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Purified Human Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Protease Inhibitors Market

Antiretroviral Protease Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Trypsin Market Research Report 2024

Animal Free Trypsin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Component free Trypsin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Thrombin Market Research Report 2024

Alpha 1 Antitrypsin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Industrial Proteases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pepstatin A Market Research Report 2024

Global Papain Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Human Coagulation Factor VII Market Insights Forecast to 2030

Global Prolastin Market Insights Forecast to 2030

C1 Esterase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antipain Dihydrochloride Market Research Report 2024

Global SERPINE1 ELISA Kits Market Research Report 2024

Global Leupeptin Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions